121 related articles for article (PubMed ID: 34270986)
21. TSA suppresses miR-106b-93-25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC.
Zhao ZN; Bai JX; Zhou Q; Yan B; Qin WW; Jia LT; Meng YL; Jin BQ; Yao LB; Wang T; Yang AG
PLoS One; 2012; 7(9):e45133. PubMed ID: 23028803
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway.
Boreddy SR; Pramanik KC; Srivastava SK
Clin Cancer Res; 2011 Apr; 17(7):1784-95. PubMed ID: 21350002
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis induced by 7-difluoromethoxyl-5,4'-di-n-octyl genistein via the inactivation of FoxM1 in ovarian cancer cells.
Ning Y; Li Q; Xiang H; Liu F; Cao J
Oncol Rep; 2012 Jun; 27(6):1857-64. PubMed ID: 22447287
[TBL] [Abstract][Full Text] [Related]
24. JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer.
Qiu H; Jackson AL; Kilgore JE; Zhong Y; Chan LL; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2015 Mar; 6(9):6915-30. PubMed ID: 25762632
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer.
Roy SK; Srivastava RK; Shankar S
J Mol Signal; 2010 Jul; 5():10. PubMed ID: 20642839
[TBL] [Abstract][Full Text] [Related]
26. Role of FOXO protein's abnormal activation through PI3K/AKT pathway in platinum resistance of ovarian cancer.
Shi YY; Meng XT; Xu YN; Tian XJ
J Obstet Gynaecol Res; 2021 Jun; 47(6):1946-1957. PubMed ID: 33827148
[TBL] [Abstract][Full Text] [Related]
27. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a.
Huang L; Wang HY; Li JD; Wang JH; Zhou Y; Luo RZ; Yun JP; Zhang Y; Jia WH; Zheng M
Cell Death Dis; 2013 Aug; 4(8):e745. PubMed ID: 23907459
[TBL] [Abstract][Full Text] [Related]
28. The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimulation.
Xu X; Dong Z; Li Y; Yang Y; Yuan Z; Qu X; Kong B
Int J Biochem Cell Biol; 2013 Mar; 45(3):536-45. PubMed ID: 23262295
[TBL] [Abstract][Full Text] [Related]
29. C-Myc inhibition sensitizes pre-B ALL cells to the anti-tumor effect of vincristine by altering apoptosis and autophagy: Proposing a probable mechanism of action for 10058-F4.
Sheikh-Zeineddini N; Safaroghli-Azar A; Salari S; Bashash D
Eur J Pharmacol; 2020 Mar; 870():172821. PubMed ID: 31770526
[TBL] [Abstract][Full Text] [Related]
30. Effect of Saponin from Tupistra chinensis Baker on proliferation and apoptosis of ovarian cancer cells by Wnt/β-Catenin pathway.
Ji X; Yang C; Xie J; Yin X; Hu Q
IUBMB Life; 2020 Aug; 72(8):1780-1786. PubMed ID: 32502299
[TBL] [Abstract][Full Text] [Related]
31. Targeting of the MYCN protein with small molecule c-MYC inhibitors.
Müller I; Larsson K; Frenzel A; Oliynyk G; Zirath H; Prochownik EV; Westwood NJ; Henriksson MA
PLoS One; 2014; 9(5):e97285. PubMed ID: 24859015
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of c-Myc by 10058-F4 induces growth arrest and chemosensitivity in pancreatic ductal adenocarcinoma.
Zhang M; Fan HY; Li SC
Biomed Pharmacother; 2015 Jul; 73():123-8. PubMed ID: 26211592
[TBL] [Abstract][Full Text] [Related]
33. Bithionol inhibits ovarian cancer cell growth in vitro - studies on mechanism(s) of action.
Ayyagari VN; Brard L
BMC Cancer; 2014 Feb; 14():61. PubMed ID: 24495391
[TBL] [Abstract][Full Text] [Related]
34. Myc and PI3K/AKT signaling cooperatively repress FOXO3a-dependent PUMA and GADD45a gene expression.
Amente S; Zhang J; Lavadera ML; Lania L; Avvedimento EV; Majello B
Nucleic Acids Res; 2011 Dec; 39(22):9498-507. PubMed ID: 21835778
[TBL] [Abstract][Full Text] [Related]
35. A novel phosphatidylinositol 3-kinase (PI3K) inhibitor directs a potent FOXO-dependent, p53-independent cell cycle arrest phenotype characterized by the differential induction of a subset of FOXO-regulated genes.
Hill R; Kalathur RK; Callejas S; Colaço L; Brandão R; Serelde B; Cebriá A; Blanco-Aparicio C; Pastor J; Futschik M; Dopazo A; Link W
Breast Cancer Res; 2014 Dec; 16(6):482. PubMed ID: 25488803
[TBL] [Abstract][Full Text] [Related]
36. The involvement of FoxO in cell survival and chemosensitivity mediated by Mirk/Dyrk1B in ovarian cancer.
Gao J; Yang X; Yin P; Hu W; Liao H; Miao Z; Pan C; Li N
Int J Oncol; 2012 Apr; 40(4):1203-9. PubMed ID: 22159921
[TBL] [Abstract][Full Text] [Related]
37. Berbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing Smad3 activity.
Liang Y; Qiu X; Xu RZ; Zhao XY
J Zhejiang Univ Sci B; 2011 Jul; 12(7):568-74. PubMed ID: 21726064
[TBL] [Abstract][Full Text] [Related]
38. Quercetin induces growth arrest through activation of FOXO1 transcription factor in EGFR-overexpressing oral cancer cells.
Huang CY; Chan CY; Chou IT; Lien CH; Hung HC; Lee MF
J Nutr Biochem; 2013 Sep; 24(9):1596-603. PubMed ID: 23618529
[TBL] [Abstract][Full Text] [Related]
39. [Proliferation and apoptosis effect of rosiglitazone on human ovarian cancer cell line SKOV3].
Ren QC; Peng ZL; Tan X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):217-22. PubMed ID: 19462893
[TBL] [Abstract][Full Text] [Related]
40. Nobiletin (NOB) suppresses autophagic degradation via over-expressing AKT pathway and enhances apoptosis in multidrug-resistant SKOV3/TAX ovarian cancer cells.
Jiang YP; Guo H; Wang XB
Biomed Pharmacother; 2018 Jul; 103():29-37. PubMed ID: 29635125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
